Edwards Lifesciences Corporation (ETR:EWL)
Germany flag Germany · Delayed Price · Currency is EUR
68.71
-1.36 (-1.94%)
At close: Aug 1, 2025, 5:30 PM CET

Edwards Lifesciences Revenue

Edwards Lifesciences had revenue of $1.53B USD in the quarter ending June 30, 2025, with 13.29% growth. This brings the company's revenue in the last twelve months to $5.69B, up 9.50% year-over-year. In the year 2024, Edwards Lifesciences had annual revenue of $5.44B with 8.57% growth.

Revenue (ttm)
$5.69B
Revenue Growth
+9.50%
P/S Ratio
8.34
Revenue / Employee
$359.82K
Employees
15,800
Market Cap
40.39B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.44B429.50M8.57%
Dec 31, 20235.01B546.00M12.23%
Dec 31, 20224.46B-768.50M-14.69%
Dec 31, 20215.23B846.20M19.29%
Dec 31, 20204.39B38.30M0.88%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition